Evidence map›Paper›PMID 41129518›Full record

ArticlePloS one2025

Efficient two-step chemoenzymatic conjugation of antibody fragments with reporter compounds by a specific thiol-PEG-amine Linker, HS-PEG-NH2.

Haruya Sato, Yukiko Kataoka, Youichi Nishikawa, Daiki Okano, Mami Nagai, Yoshio Yamauchi, Masato Taoka, Katsuki Naitoh

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Haruya SatoCentral Research Laboratories, Sysmex Corporation, Healthcare Science Hub Tokyo, Tokyo, Japan.ORCID https://orcid.org/0009-0008-0134-3650
Yukiko KataokaBio-Diagnostic Reagent Technology Center, Technology Innovation, Sysmex Corporation, Healthcare Science Hub Tokyo, Tokyo, Japan.
Youichi NishikawaCentral Research Laboratories, Sysmex Corporation, Kobe, Hyogo, Japan.
Daiki OkanoReagent Engineering, Sysmex Corporation, Kobe, Hyogo, Japan.
Mami NagaiReagent Engineering, Sysmex Corporation, Healthcare Science Hub Tokyo, Tokyo, Japan.
Yoshio YamauchiDepartment of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Masato TaokaDepartment of Chemistry, Graduate School of Science, Tokyo Metropolitan University, Tokyo, Japan.
Katsuki NaitohStrategic Technology Planning, Technology Strategy, Sysmex, Corporation Healthcare Science Hub Tokyo, Tokyo, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chemoenzymatic conjugation of antibodies with reporter compounds offers broad applicability for detecting target antigens in the context of in vitro research and diagnostics. For conjugation, a bifunctional linker with a protected thiol and an amino group, serving as a transglutaminase substrate, is often employed. However, protective groups require an additional deprotection step during synthesis. To overcome this limitation, we selected a long-chain thiol-PEG-amine (HS-PEG) linker as the substrate. The HS-PEG linker exhibited minimal S-S bond dimerization in solution and was efficiently conjugated to Fab containing the transglutaminase-specific sequence tag (Q-tag), retaining the free state of the SH group. Using this SH group, a reporter compound containing two types of activated maleimides, Alexa488 or the red algae-derived fluorescent dye phycoerythrin, was conjugated to Fab. Both conjugates formed uniform structures in just two synthetic steps without compromising antigen-binding activity. Among the conjugates, phycoerythrin conjugated with multiple Fab molecules showed higher activity than that conjugated with fewer molecules in fluorescence enzyme-linked immunosorbent assays (ELISA) and flow cytometry. These results indicate that the chemoenzymatic approach using the HS-PEG linker and transglutaminase facilitates uniform Fab conjugation with reporter molecules for in vitro research and diagnostic applications. This method can expand the application of chemoenzymatic modification of antibody fragments by simplifying the conjugation process and reducing the formation of by-products.

Indexed as

AminesImmunoconjugatesImmunoglobulin Fab FragmentsPolyethylene GlycolsSulfhydryl CompoundsAnimalsHumansTransglutaminasesAminesImmunoconjugatesImmunoglobulin Fab FragmentsPolyethylene GlycolsSulfhydryl CompoundsTransglutaminases

Identifiers

PMID41129518
PMCPMC12548897

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.